Arphion creates non-invasive diagnostics for oral cancers and other benign diseases. They utilize miRNA markers from cheek swabs to diagnose oral squamous cell carcinomas.

Arphion provides its clients with tests as a Laboratory Developed Test (LDT) through a CLIA-certified laboratory to market their products without submission to the FDA for